By: IPP Bureau
Last updated : June 03, 2026 7:43 pm
Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
FITT IIT (Indian Institute of Technology) Delhi, in collaboration with Pfizer India and ecosystem partner Social Alpha, successfully hosted the event titled, "Translating What's Next: Securing the Future of Innovation" at its New Delhi campus.
The centrepiece of the event was the unveiling of 20 winning startups of the Pfizer INDovation Program (IP Support Edition) 2025–26 - a flagship, first-of-its-kind initiative, purpose-built to accelerate India's next generation of healthcare and innovators.
The event brought together an extraordinary assembly of leaders spanning healthcare, public policy, academia, venture capital, and India's startup ecosystem - all united by a shared conviction that India's moment in global healthcare innovation has arrived. What unfolded was more than a conference; it was a declaration of intent.
The program, a part of Pfizer's Corporate Social Responsibility initiative, provides winning ventures with end-to-end technical and legal IP consultation, comprehensive commercialisation support, and privileged access to a curated network of investors, venture capitalists, and seasoned industry mentors.
"The Ayushman Bharat Digital Mission is not merely a government scheme - it is the digital spine of a new India. Interoperable health infrastructure, data-driven systems, and technology-enabled access will fundamentally rewrite who gets care, when they get it, and how," said Dr. M. Srinivas, Former Director, AIIMS New Delhi & Member (Health), NITI Aayog.
Bhuvnesh Pratap Singh, Director, Startup India in his address connected the ambitions of individual startup founders to the national vision of a self-reliant, innovation-powered India by 2047. He underscored the indispensable role of accessible healthcare technologies in realising this vision.
"The gap between a breakthrough in a laboratory and a breakthrough in the market is where most innovations die. Closing that gap requires bold industry-academia partnerships, relentless translational research, and startups willing to bet on deep tech,” said Tarun Chaturvedi, COO, FITT IIT Delhi.
"We at Pfizer recognize that sustainable healthcare transformation cannot happen in silos, but demands innovation enablers, cross-border collaboration, and ecosystem partnerships to translate breakthroughs into real impact for people around the world,” said Sharad Goswami, Senior Director, Global Policy & International Public Affairs, Pfizer India.